Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

LIVMOTY DIN 02559552

Status: Approved
Holder: JANSSEN INC
Molecule: GOLIMUMAB

Health Canada record

Active ingredient(s)GOLIMUMAB 50 MG
Dosage formSolution
RouteSubcutaneous
SchedulePRESCRIPTION; SCHEDULE D
ClassHuman
ATCL04AB06 GOLIMUMAB
Original market date
Current status date17-Jul-2025
SourceHealth Canada DPD

Establishment licence of the holder

Janssen Inc — licence 100239, currently licensed, last inspection rating C (2026-03-09).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing GOLIMUMAB

DINProductCompanyFormStrengthStatus
02559560LIVMOTYJANSSEN INCSolutionGOLIMUMAB 50 MGApproved
02559536LIVMOTYJANSSEN INCSolutionGOLIMUMAB 100 MGApproved
02559544LIVMOTYJANSSEN INCSolutionGOLIMUMAB 100 MGApproved
02413183SIMPONIJANSSEN INCSolutionGOLIMUMAB 100 MGMarketed
02324776SIMPONIJANSSEN INCSolutionGOLIMUMAB 50 MGMarketed
02324784SIMPONIJANSSEN INCSolutionGOLIMUMAB 50 MGMarketed
02413175SIMPONIJANSSEN INCSolutionGOLIMUMAB 100 MGMarketed
02417472SIMPONI I.V.JANSSEN INCSolutionGOLIMUMAB 50 MGMarketed
02567393UPGOLYVJAMP PHARMA CORPORATIONSolutionGOLIMUMAB 50 MGApproved
02567407UPGOLYVJAMP PHARMA CORPORATIONSolutionGOLIMUMAB 100 MGApproved
02567415UPGOLYVJAMP PHARMA CORPORATIONSolutionGOLIMUMAB 100 MGApproved
02567423UPGOLYVJAMP PHARMA CORPORATIONSolutionGOLIMUMAB 50 MGApproved

Notices of Compliance

NOCDateSubmissionReason
356862025-07-17New Drug Submission (NDS)Administrative – Additional Product Name
Request a quote for LIVMOTY

How to read a Canadian DIN record